Close Menu

metabolomics

Agilent is providing the center with two mass spec systems for metabolomics work: a 6495 triple quadrupole LC/MS system and a 6550 iFunnel QTOF LC/MS 

In PLOS this week: loci linked to aggressive prostate cancer, metabolic profiling of mice with Chagas disease, and more.

NEW YORK (GenomeWeb) – Beckman Coulter today announced a collaboration with the University of Birmingham, UK aimed at research into higher-throughput biology.

NEW YORK (GenomeWeb) – Agilent Technologies today announced a collaboration with scientists from the University of Toronto's Donnelly Centre for Cellular and Biomolecular Research to create a comprehensive metabolomics multiple-reaction monitoring library and methodology.

NEW YORK (GenomeWeb) – The National Science Foundation has awarded $2.5 million to researchers from 11 institutions to conduct studies, including sequencing-based analysis, of the evolution of zygomycetes.

NEW YORK (GenomeWeb) – Metabolon today announced a partnership with Spanish biomedical firm Metdia Biotech to commercialize the Quantose IR and Quantose IGT prediabetes tests in 14 European countries.

NEW YORK (GenomeWeb) – Metabolon announced that it is partnering with Geisinger Medical Center in Danville, Pa., on a pilot study to evaluate Metabolon's Quantose IR test in monitoring glycemic control in people with prediabetes.

NEW YORK (GenomeWeb) – Metabolon today announced a collaboration to provide metabolomic profiling services to GlaxoSmithKline.

NEW YORK (GenomeWeb News) – George Washington University said today that it and collaborators have received up to $14.6 million from the Defense Advanced Research Projects Agency to develop an approach to rapidly identify the mechanisms of biological and chemical threats.

Pages

A man has confessed to the rape and murder of developmental biologist Suzanne Eaton, according to the New York Times.

The Irish Times reports that US lawmakers and law enforcement agencies are concerned about ties between the US and Chinese genomics firms.

Parents of children with spinal muscular atrophy tell the Washington Post they are pushing to get insurance coverage of Novartis's Zolgensma.

In PNAS this week: gene mutations in individuals with syndromic craniosynostosis, putative colorectal cancer drivers, and more.